CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglionia immune responses in vivo

Keyphrases

• Tumor Growth 100%
• Immune Response 100%
• Treg 100%
• Glioma 100%
• CD4+CD25+ Regulatory T Cells 100%
• CD4 Treg 100%
• CD4+ 66%
• Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) 66%
• Tumor 33%
• Immune Escape 33%
• Tumor Cells 33%
• Glioma Cells 33%
• Syngeneic 33%
• Brain Tumor 33%
• CD25 33%
• T-cell Mediated 33%
• Glioma Model 33%
• Tumor Accumulation 33%
• C-X-C Chemokine Receptor Type 4 (CXCR4) 33%
• CD4 T Cells 33%
• Autoimmunity 33%
• Monoclonal Antibody 33%
• Antibody Titer 33%
• IgG2a 33%
• Tumor-infiltrating 33%
• Regulatory T Cell(Treg) 33%
• Treg Depletion 33%
• Anti-glioma 33%
• FoxP3+ Cells 33%
• Anti-CD25 Antibody 33%
• CD8 T Cells 33%
• Immune-mediated 33%
• Moving Tumor 33%
• Suppressive Activity 33%
• Glioma Immunotherapy 33%
• CD8+ Effector T Cells 33%
• Tumor Eradication 33%

Immunology and Microbiology

• Regulatory T Cell 100%
• Immune Response 100%
• CD4 100%
• CTLA-4 20%
• T Cell 10%
• Immune Escape 10%
• Immunotherapy 10%
• Tumor Cell 10%
• Glioma Cell 10%
• Syngenic 10%
• CD25 10%
• Upregulation 10%
• Cytotoxic T-Cell 10%
• T-Helper Cell 10%
• CXCR4 10%
• Autoimmunity 10%
• Monoclonal Antibody 10%
• CD8 10%
• Antibody Titer 10%
• Basiliximab 10%
• Immunoglobulin G2a Antibody 10%